Last reviewed · How we verify

NCT04961255

Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit

Status unknown Last updated 5 December 2023
What this trial tests

trial in Post-COVID-19 in 90 participants. Status unknown.

Timeline
24 August 2021
Primary endpoint
30 August 2024
30 December 2024

Quick facts

Lead sponsorUniversity of Brasilia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment90
Start date24 August 2021
Primary completion30 August 2024
Estimated completion30 December 2024
Sites1 location across Brazil

Conditions studied

Sponsor

University of Brasilia

Who can join

Adults 18 to 80, any sex, with Post-COVID-19 or Healthy Participants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The physiological/biomechanical characteristics related to muscle and tendon architecture and their possible relationship with the loss of muscle strength and fatigue in patients who were infected with COVID-19 are totally unknown. The aim of this study is to evaluate inflammatory markers, the isometric maximum voluntary force of the knee extensor torque, muscle fatigue, neuromuscular adaptations, muscle architecture, tendinous properties of quadriceps components, oxygen extraction, and body composition in participants after diagnosis with Covid-19 who had moderate and severe levels of involvement compared to a healthy control group.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Intra- and Inter-Rater Reliability and Agreement of Ultrasound Imaging of Muscle Architecture and Patellar Tendon in Post-COVID-19 Patients Who Had Experienced Moderate or Severe COVID-19 Infection.
    de Jesus Ferreira LG, de Almeida Ventura Á, da Silva Almeida I, Mansur H, et al · · 2022 · cited 5× · PMID 36498509 · DOI 10.3390/jcm11236934
  2. Fatigue and neuromuscular function in long COVID: A one-year follow-up study.
    Almeida IDS, Ferreira LGJ, Vaz MA, Cipriano Junior G, et al · · 2025 · cited 1× · PMID 40991619 · DOI 10.1371/journal.pone.0332242
  3. Impact of COVID-19 on patellar tendon properties over the first year after infection.
    de Jesus Ferreira LG, da Silva Almeida I, Costa RR, Roriz GV, et al · · 2026 · PMID 41501086 · DOI 10.1038/s41598-025-06879-w
  4. Persistent neuromuscular disorders associated with changes in tibialis anterior and gastrocnemius lateralis muscle architecture in long-covid: an observational longitudinal study.
    da Silva Almeida I, de Jesus Ferreira LG, Cipriano G, Costa RR, et al · · 2025 · PMID 41038893 · DOI 10.1038/s41598-025-17126-7
  5. Long COVID-19 alters muscle architecture and muscle-tendon force transmission: a one-year longitudinal study.
    Ferreira LGJ, da Silva Almeida I, Costa RR, Roriz GV, et al · · 2025 · PMID 40926885 · DOI 10.3389/fphys.2025.1641046

Verify or expand the search:

Other University of Brasilia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing